128 related articles for article (PubMed ID: 27019377)
1. Nevus Anemicus As an Additional Diagnostic Marker of Neurofibromatosis Type 1 in Childhood.
Vaassen P; Rosenbaum T
Neuropediatrics; 2016 Jun; 47(3):190-3. PubMed ID: 27019377
[TBL] [Abstract][Full Text] [Related]
2. Juvenile xanthogranuloma and nevus anemicus in the diagnosis of neurofibromatosis type 1.
Ferrari F; Masurel A; Olivier-Faivre L; Vabres P
JAMA Dermatol; 2014 Jan; 150(1):42-6. PubMed ID: 24258576
[TBL] [Abstract][Full Text] [Related]
3. Nevus anemicus in neurofibromatosis type 1: a potential new diagnostic criterion.
Marque M; Roubertie A; Jaussent A; Carneiro M; Meunier L; Guillot B; Pinson L; Pinson S; Bessis D
J Am Acad Dermatol; 2013 Nov; 69(5):768-775. PubMed ID: 23972508
[TBL] [Abstract][Full Text] [Related]
4. Nevus anemicus: a distinctive cutaneous finding in neurofibromatosis type 1.
Hernández-Martín A; García-Martínez FJ; Duat A; López-Martín I; Noguera-Morel L; Torrelo A
Pediatr Dermatol; 2015; 32(3):342-7. PubMed ID: 25690591
[TBL] [Abstract][Full Text] [Related]
5. Nevus anemicus associated with neurofibromatosis type 1 in a neonate: a case report.
Cerini C; Pogliani L; Mameli C; Zuccotti GV
G Ital Dermatol Venereol; 2015 Dec; 150(6):745-7. PubMed ID: 26513044
[TBL] [Abstract][Full Text] [Related]
6. Cutaneous Manifestations not Considered Diagnostic Criteria for Neurofibromatosis Type 1. A Case-Control Study.
García-Martínez FJ; Duat-Rodríguez A; Andrés Esteban E; Torrelo A; Noguera Morel L; Hernández-Martín A
Actas Dermosifiliogr; 2022; 113(10):T923-T929. PubMed ID: 36162491
[TBL] [Abstract][Full Text] [Related]
7. Cutaneous Manifestations not Considered Diagnostic Criteria for Neurofibromatosis Type 1. A Case-Control Study.
García-Martínez FJ; Duat-Rodríguez A; Andrés Esteban E; Torrelo A; Noguera Morel L; Hernández-Martín A
Actas Dermosifiliogr; 2022; 113(10):923-929. PubMed ID: 35636506
[TBL] [Abstract][Full Text] [Related]
8. Minor disease features in neurofibromatosis type 1 (NF1) and their possible value in diagnosis of NF1 in children < or = 6 years and clinically suspected of having NF1. Neurofibromatosis team of Sophia Children's Hospital.
Cnossen MH; Moons KG; Garssen MP; Pasmans NM; de Goede-Bolder A; Niermeijer MF; Grobbee DE
J Med Genet; 1998 Aug; 35(8):624-7. PubMed ID: 9719365
[TBL] [Abstract][Full Text] [Related]
9. Seizures in children with neurofibromatosis type 1: is neurofibromatosis type 1 enough?
Santoro C; Bernardo P; Coppola A; Pugliese U; Cirillo M; Giugliano T; Piluso G; Cinalli G; Striano S; Bravaccio C; Perrotta S
Ital J Pediatr; 2018 Mar; 44(1):41. PubMed ID: 29566708
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of neurofibromatosis type 1 in congenital pseudarthrosis of the tibia.
Van Royen K; Brems H; Legius E; Lammens J; Laumen A
Eur J Pediatr; 2016 Sep; 175(9):1193-1198. PubMed ID: 27519821
[TBL] [Abstract][Full Text] [Related]
11. [Children with neurofibroma type 1 treated in the Children's Memorial Health Institute].
Perek-Polnik M; Filipek I; Dembowska-Bagińska B; Owsik A; Drogosiewicz M; Jurkiewicz E; Perek D
Med Wieku Rozwoj; 2006; 10(3 Pt 1):699-709. PubMed ID: 17317901
[TBL] [Abstract][Full Text] [Related]
12. Epileptic seizures in neurofibromatosis type 1 are related to intracranial tumors but not to neurofibromatosis bright objects.
Hsieh HY; Fung HC; Wang CJ; Chin SC; Wu T
Seizure; 2011 Oct; 20(8):606-11. PubMed ID: 21621428
[TBL] [Abstract][Full Text] [Related]
13. Large number of cutaneous neurofibromas beyond age-appropriate incidence in a patient with a large deletion of NF1.
Yoshida Y; Ehara Y; Kosaki K; Yamamoto O
J Dermatol; 2018 Mar; 45(3):363-364. PubMed ID: 29498099
[No Abstract] [Full Text] [Related]
14. Use of "unidentified bright objects" on MRI for diagnosis of neurofibromatosis 1 in children.
DeBella K; Poskitt K; Szudek J; Friedman JM
Neurology; 2000 Apr; 54(8):1646-51. PubMed ID: 10762507
[TBL] [Abstract][Full Text] [Related]
15. Optic Pathway Glioma and Cerebral Focal Abnormal Signal Intensity in Patients with Neurofibromatosis Type 1: Characteristics, Treatment Choices and Follow-up in 134 Affected Individuals and a Brief Review of the Literature.
Friedrich RE; Nuding MA
Anticancer Res; 2016 Aug; 36(8):4095-121. PubMed ID: 27466519
[TBL] [Abstract][Full Text] [Related]
16. [Phenotypic and genetic features in neurofibromatosis type 1 in children].
Duat Rodríguez A; Martos Moreno GÁ; Martín Santo-Domingo Y; Hernández Martín A; Espejo-Saavedra Roca JM; Ruiz-Falcó Rojas ML; Argente J
An Pediatr (Barc); 2015 Sep; 83(3):173-82. PubMed ID: 25541118
[TBL] [Abstract][Full Text] [Related]
17. Anemic nevus in neurofibromatosis type 1.
Tadini G; Brena M; Pezzani L; Gelmetti C; Santagada F; Boldrini MP
Dermatology; 2013; 226(2):115-8. PubMed ID: 23713063
[TBL] [Abstract][Full Text] [Related]
18. In Vivo Detection of Choroidal Abnormalities Related to NF1: Feasibility and Comparison With Standard NIH Diagnostic Criteria in Pediatric Patients.
Parrozzani R; Clementi M; Frizziero L; Miglionico G; Perrini P; Cavarzeran F; Kotsafti O; Comacchio F; Trevisson E; Convento E; Fusetti S; Midena E
Invest Ophthalmol Vis Sci; 2015 Sep; 56(10):6036-42. PubMed ID: 26393470
[TBL] [Abstract][Full Text] [Related]
19. What's new with common genetic skin disorders?
Hand JL
Curr Opin Pediatr; 2015 Aug; 27(4):460-5. PubMed ID: 26164153
[TBL] [Abstract][Full Text] [Related]
20. Clinical and mutational spectrum of neurofibromatosis type 1-like syndrome.
Messiaen L; Yao S; Brems H; Callens T; Sathienkijkanchai A; Denayer E; Spencer E; Arn P; Babovic-Vuksanovic D; Bay C; Bobele G; Cohen BH; Escobar L; Eunpu D; Grebe T; Greenstein R; Hachen R; Irons M; Kronn D; Lemire E; Leppig K; Lim C; McDonald M; Narayanan V; Pearn A; Pedersen R; Powell B; Shapiro LR; Skidmore D; Tegay D; Thiese H; Zackai EH; Vijzelaar R; Taniguchi K; Ayada T; Okamoto F; Yoshimura A; Parret A; Korf B; Legius E
JAMA; 2009 Nov; 302(19):2111-8. PubMed ID: 19920235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
